Naloxone may be beneficial in the treatment of tardive dyskinesia.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009270:Naloxone / Q000627:therapeutic use*; D013997:Time Factors
D009270:Naloxone